Clinical Trial Update: A Study of Alpelisib and Fulvestrant to Treat Endometrial Cancer [Phase 2]

View source ↗

Summary

This clinical trial update reports a Phase 2 study of alpelisib combined with fulvestrant for endometrial cancer. The trial is currently active but not recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• Faslodex (fulvestrant)
• Piqray (alpelisib)

Snippet

Sponsor: GOG Foundation | Conditions: Endometroid Endometrial Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING